Literature DB >> 1091964

In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours.

J Jos, G Lenoir, D Ritis G, J Rey.   

Abstract

Jos, J., Lenoir, G., de Ritis, G. & Rey, J. In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours. Scand. J. Gastroent. 1975, 10, 121-128. Intestinal biopsies from controls and from children with treated or untreated coeliac disease were cultured for 48 hours in the presence or absence of various peptic-tryptic (P.T.) or peptic-tryptic-chymotryptic (P.T.C.) digests of gliadin and casein, using a modified organ culture method. In flat biopsy specimens obtained from children with active coeliac disease and maintained in culture in the presence of P.T. or P.T.C. digests of gliadin, whether autoclaved or not, a cytotoxic effect was obvious; but this effect was in part unspecific, since P.T. digests of casein were also slightly noxious in such experimental conditions. Biopsies from controls or from children with coeliac disease in remission were not affected by the presence in culture medium of casein or gliadin digests, whereas coeliac biopsies, also obtained from patients in remission but after gluten challenge, were specifically injured during culture with gliadin peptides. On the other hand, a thorough P.T.C. hydrolysis of gliadin abolished all its in vitro noxious effects, suggesting that its toxicity is related to a relatively large peptide.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091964

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  12 in total

1.  Coeliac disease: A review of the causative agents and their possible mechanisms of action.

Authors:  H J Cornell
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

2.  Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.

Authors:  S Fais; L Maiuri; F Pallone; M De Vincenzi; G De Ritis; R Troncone; S Auricchio
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Organ culture of adult mouse intestine. III. Behavior of the proteins, DNA content and brush border membrane enzymatic activities.

Authors:  A Berteloot; J G Chabot; D Menard; J S Hugon
Journal:  In Vitro       Date:  1979-04

4.  Organ culture of rabbit ileum as a model for the investigation of the mechanism of intestinal damage by enteropathogenic Escherichia coli.

Authors:  R M Batt; C A Hart; L McLean; J R Saunders
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

Review 5.  Organ culture of gastrointestinal mucosa--a technique for the study of the human gastrointestinal tract.

Authors:  P D Howdle
Journal:  Postgrad Med J       Date:  1984-10       Impact factor: 2.401

6.  Alkaline phosphatase synthesis and properties of subcellular organelles during in vitro culture of jejunal biopsies from control subjects and patients with coeliac disease.

Authors:  P E Jones; C L'Hirondel; T J Peters
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

7.  Organ culture of coeliac and non-coeliac small intestinal mucosa.

Authors:  F M Stevens; R Keane; P F Fottrell; B McNicholl; C F McCarthy
Journal:  Ir J Med Sci       Date:  1978-01       Impact factor: 1.568

8.  In vitro diagnosis of coeliac disease: an assessment.

Authors:  P D Howdle; G R Corazza; A W Bullen; M S Losowsky
Journal:  Gut       Date:  1981-11       Impact factor: 23.059

9.  Organ culture of adult mouse intestine. II. Mitotic activity, DNA synthesis and cellular migration after 24 and 48 hours of culture.

Authors:  S Ferland; J S Hugon
Journal:  In Vitro       Date:  1979-04

10.  Re-evaluation of the techique of organ culture for studying gluten toxicity in coeliac disease.

Authors:  H P Hauri; M Kedinger; K Haffen; H Gaze; B Hadorn; W Hekkens
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.